Prescribing certain controlled medications via telehealth was a lifeline for health center patients during the pandemic. A pending rule from the Drug Enforcement Administration (DEA) is under review but could curtail tele-prescribing of controlled substances. Without a proposed rule, tele-prescribing flexibility expires this year on Dec. 31. NACHC and other stakeholders are pushing for the White House to ensure these flexibilities are extended for two additional years.
